Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
- Robson M, Im SA, Senkus E, et al. Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation. N Engl J Med. 2017;10;377(6):523-533.
- Litton JK, Rugo HS, Ettl J, et al. Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation. N Engl J Med. 2018;379(8):753-763.
- André F, Ciruelos EM, Rubovszky G. SOLAR-1: Alpelisib in Patients With PIK3CA-Mutated HR-Positive, HER2-Negative Advanced Breast Cancer. Paper presented at: the European Society for Medical Oncology (ESMO) 2018 Congress; October 19–23, 2018; Munich, Germany. Abstract LBA_PR.
- Schmid P, Adams S, Rugo HS, et al. Atezolizumab Plus Nab-Paclitaxel in Metastatic Triple-Negative Breast Cancer. N Engl J Med. 2018 Nov 29;379(22):2108-2121.
Disclosure statements are available on the authors' profiles: